Evidence map›Paper›PMID 32384154›Full record

ArticleBlood2020

The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.

Caroline A Enns, Shall Jue, An-Sheng Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Molecular and therapeutic frontiers in anemia therapy.The Journal of clinical investigation · 2026
    Review
  2. Article
  3. Review
  4. Systemic Iron Metabolism.Advances in experimental medicine and biology · 2025
    Review
  5. Review
  6. Iron Deficiency Anemia.Advances in experimental medicine and biology · 2025
    Review
  7. Review
  8. Review
  9. RationalJournal of medicinal chemistry · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Managing the Dual Nature of Iron to Preserve Health.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Hepcidin and Iron in Health and Disease.Annual review of medicine · 2023
    Review
  16. Article
  17. Article
  18. The mutual crosstalk between iron and erythropoiesis.International journal of hematology · 2022
    Review
  19. Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Caroline A EnnsDepartment of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR.
Shall JueDepartment of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR.
An-Sheng ZhangDepartment of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR.
Oregon Health & Science University · US

Funding

ROLES OF NEOGENIN AND MATRIPTASE-2 IN IRON HOMEOSTASISR01DK102791 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAROLINE ENNS, An-Sheng Zhang · 2015 to 2026
$6.1M
Regulation and function of transferrin receptor 2R01DK072166 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI ENNS, CAROLINE · 2005 to 2017
$3.7M
NIDDK NIH HHS R01 DK072166NIDDK NIH HHS R01 DK102791
6 · The paper itself

Abstract

Matriptase-2 (MT2), encoded by TMPRSS6, is a membrane-anchored serine protease that plays a key role in suppressing hepatic hepcidin expression. MT2 is synthesized as a zymogen and undergoes autocleavage for activation. Previous studies suggest that MT2 suppresses hepcidin by cleaving hemojuvelin and other components of the bone morphogenetic protein-signaling pathway. However, the underlying mechanism is still debatable. Here we dissected the contributions of the nonproteolytic and proteolytic activities of Mt2 by taking advantage of Mt2 mutants and Tmprss6-/- mice. Studies of the protease-dead full-length Mt2 (Mt2S762A) and the truncated Mt2 that lacks the catalytic domain (Mt2mask) indicate that the catalytic domain, but not its proteolytic activity, was required for Mt2 to suppress hepcidin expression. This process was likely accomplished by the binding of Mt2 ectodomain to Hjv and Hfe. We found that Mt2 specifically cleaved the key components of the hepcidin-induction pathway, including Hjv, Alk3, ActRIIA, and Hfe, when overexpressed in hepatoma cells. Nevertheless, studies of a murine iron-refractory iron-deficiency anemia-causing mutant (Mt2I286F) in the complement protein subcomponents C1r/C1s, urchin embryonic growth factor, and bone morphogenetic protein 1 domain indicate that Mt2I286F can be activated, but it exhibited a largely compromised ability to suppress hepcidin expression. Coimmunoprecipitation analysis revealed that Mt2I286F, but not Mt2S762A, had reduced interactions with Hjv, ActRIIA, and Hfe. In addition, increased expression of a serine protease inhibitor, the hepatocyte growth factor activator inhibitor-2, in the liver failed to alter hepcidin. Together, these observations support the idea that the substrate interaction with Mt2 plays a determinant role and suggest that the proteolytic activity is not an appropriate target to modulate the function of MT2 for clinical applications.

Indexed as

AnimalsCells, CulturedGene Expression RegulationHEK293 CellsHepcidinsHumansMembrane ProteinsMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutProtein Interaction Domains and MotifsProteolysisSerine EndopeptidasesHepcidinsmatriptase 2Membrane ProteinsSerine EndopeptidasesTMPRSS6 protein, human

Identifiers

PMID32384154
PMCPMC7441170
OpenAlexW3023843750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.